Loading insider details...
Latest Form 4 (Oct 22, 2026): In-the-Money Exercise of 485,830 SRZN shares, $5.64M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 22, 2026 | Surrozen, Inc./DE (SRZN) | In-the-Money Exercise | 485,830 | $5.64M |
| Sep 8, 2026 | Eikon Therapeutics, Inc. (EIKN) | Purchase | 89,200 | $1.03M |
| May 19, 2026 | Surrozen, Inc./DE (SRZN) | Grant/Award | 5,550 | n/a |
| Feb 26, 2026 | Tenaya Therapeutics, Inc. (TNYA) | Sale | 309,228 | $190.3K |
| Feb 24, 2026 | Tenaya Therapeutics, Inc. (TNYA) | Sale | 245,965 | $151.2K |
| Feb 12, 2026 | Tenaya Therapeutics, Inc. (TNYA) | Sale | 161,422 | $131.7K |
| Feb 10, 2026 | Eikon Therapeutics, Inc. (EIKN) | Conversion | 1,296,629 | n/a |
| Jan 21, 2026 | Surrozen, Inc./DE (SRZN) | Purchase | 5,590 | $111.2K |
| Jan 15, 2026 | Surrozen, Inc./DE (SRZN) | Purchase | 5,861 | $116.1K |
| Jan 8, 2026 | Surrozen, Inc./DE (SRZN) | Purchase | 7,097 | $141.1K |